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Abstract 
Objectives: To prospectively assess the agreement of oro-caecal transit time (OCTT) 
measurements by lactulose hydrogen breath test (LHBT) and magnetic resonance imaging (MRI) in 
healthy subjects.  
Methods: Volunteers underwent abdominal 1.5-T MRI using axial and coronal single-shot 
fast-spin-echo T2-weighted sequences in the fasted condition and after lactulose ingestion 
(10g/125mL). Imaging and H2 excretion gas-cromatography were performed concurrently every 15 
minutes up to 180 minutes. MR images were analyzed using semiautomatic segmentation to 
calculate small bowel gas volume (SBGV) and visually to detect bolus arrival in the cecum. 
Agreement between MRI- and LHBT-OCTT was assessed. 
Results: Twenty-eight subjects (17 males/11 females;mean age±standard deviation 30±8 years) 
were evaluated. Two H2 non-producers on LHBT were excluded. OCTT measured by MRI and 
LHBT was concordant in 18/26 (69%) subjects (excellent agreement,k=0.924). Median SBGV was 
49.0 mL (interquartile interval 44.1-51.6 mL). In 8/26 (31%) subjects, MRI showed the lactulose 
bolus was in the terminal ileum and not the cecum when H2E increased on LHBT. Thus, median 
OCTT measured by MRI was significantly longer than that measured by LHBT [135min(120-150 
min)vs.127.5(105-150min);p=0.008]. Above baseline levels, correlation between [H2] and SBGV 
was significant (r=0.964;p<0.001).  
Conclusions: MRI provides valid measurements of OCTT and gas production in the small bowel. 
 
Keypoints: 
 MRI is a valid technique to measure OCTT. 
 Excellent agreement between MRI and LHBT was found. 
 Measuring gas production using MRI may provide evidence of small bowel fermentation. 
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Introduction 
Recent clinical investigations have documented abnormal GI function and oro-cecal transit time 
(OCTT) in many patients with “functional” GI diseases (1-3) such as irritable bowel syndrome 
(IBS) (4-6). Indeed, IBS studies have revealed enteric dysmotility that may cause symptoms either 
directly as a result of altered OCTT or as a consequence of impaired clearance and overgrowth of 
colonic bacteria in the small bowel (7). However routine clinical investigations of GI function are 
not, at present, able to identify the underlying causes of symptoms and disease (8). Moreover, the 
evaluation of OCTT is controversial due to important problems of the available techniques, such as 
lactulose hydrogen breath testing (LHBT), sequential scintigraphy with isotope-marked meals, or 
by magnetic resonance imaging (MRI) (9-17). 
Another important condition that is frequently linked to IBS and in which abnormal gas 
production and metabolism are implicated is small intestine bacterial overgrowth (SIBO), 
characterized by fermentation of substrates in the small bowel due to bacterial contamination from 
the caecum (18-19). Patients with SIBO complain of similar symptoms to IBS and a proportion of 
IBS patients have notable symptoms relief after antibiotic therapy (20,21). At present, the diagnosis 
of SIBO is challenging. Aspiration and culture of jejunal aspirates represent the reference standard, 
but this method is invasive, can be affected by contamination during intubation, and may be falsely 
negative as a result of a patchy bacterial distribution within the gut (22). In this setting, LHBT has 
been used to detect abnormal hydrogen excretion (H2E) due to altered bacterial distribution in the 
GI tract (23-24); recent research demonstrated that this methodology is accurate to detect OCCT, 
but has suboptimal sensitivity and specificity for SIBO detection (24,25).  
 On this basis, we performed a prospective, comparative diagnostic study to assess the 
agreement of OCTT measurements by LHBT and MRI in healthy subjects. We also compared small 
bowel gas volume (SBGV) measured using MRI to the increase in H2 excretion on LHBT to assess 
whether imaging can detect the presence of SIBO.
Materials and Methods 
Study Population 
The study protocol was approved by the local Ethics Committee and all participants gave written 
informed consent.  
Asymptomatic healthy subjects were prospectively screened to undergo LHBT and MRI 
evaluation of the small bowel. Exclusion criteria were: co-morbidity requiring active treatment (e.g. 
use of laxative, antispasmodics, drugs that affect gastric emptying, narcotics or sedatives, 
antibiotics, or anti-secretory drugs), previous abdominal surgery, contraindications to MRI 
examination and reported adverse events to lactulose.  
 
Study Protocol  
Before LHBT and MRI assessment, each subject underwent physical and clinical evaluation 
(including stool examination) and a detailed medical history. Volunteers completed a previously 
validated structured questionnaire taking into account 11 GI symptoms, each carrying a score from 
0 (no symptoms) to 3 (severe), as previously described (26). A global symptomatic score (GSS), 
calculated as the sum of all symptom scores, was assigned to each subject (maximum score=33).  
Thereafter, subjects were requested to eat a light dinner the day preceding the examination 
(21) and to fast until the examination. They were also asked to refrain from smoking and from 
physical activity the day before the test.   
 
MRI 
MRI was performed using a 1.5-T MR system (Signa Excite, General Electric, Medical Systems, 
Milwaukee, IL) equipped with a surface phased-array coil (TorsoPA, General Electrics Medical 
Systems, Milwaukee, IL). Axial and coronal T2-weighted breath-hold sequences (single-shot fast 
spin-echo, TE=90 ms, TR= 1147 ms, field of view=380×380 mm
2
, slice thickness=7 mm, two slabs 
of 20 slices, acquisition time 22 s per slab) were acquired. First acquisition served as baseline. 
Subjects with baseline abnormal amount of fluids in the stomach stopped the examination and 
repeated the test after a longer period of fasting (i.e. at least 12-15 hours). After the baseline 
acquisition, subjects were asked to use 30 mL of chlorexidine-based antiseptic oral solution 
(chlorexidine gluconate 0.12%, Oral-B, Procter & Gamble, Pomezia, Italy) to eliminate the 
possibility of oropharyngeal bacterial fermentation and, after providing a baseline H2 breath sample, 
were orally administered 10 g of lactulose (15 g of Lattulac
®
 66.7g/100 mL, Sofar, Milan, Italy) 
diluted in 125 mL of still water. Subsequently, MRI sequences and breath samples were acquired 
every 15 minutes (one time point) up to 180 minutes from lactulose administration. 
 
LHBT Evaluation 
Gas-cromatography breath analysis was performed immediately before each MRI acquisition. 
Every 15 minutes, we collected a sample of alveolar air using a system with two pockets connected 
by a T-shape valve. One 500-mL pocket was used to exclude anatomical dead space air, while the 
second was used to collect the air sample. For such purpose, subjects were instructed to take a deep 
breath, to hold it for 15 s, and then perform a forced expiration in the mouthpiece connected to the 
pockets system. Volunteers were not removed from MRI scanner during these measurements. 
Breath samples were then collected from the relevant pocket using a 30 mL syringe closed with a 
stopcock and immediately injected into a gas-chromatographer (Quintron MicroLizer™ DP plus, 
Milwaukee, IL). For each time point, H2 and CH4 concentration ([H2] and [CH4]), measured in parts 
per million (ppm) was noted. OCTT measured by LHBT (BT-OCTT) was defined as the time 
corresponding to an increase in breath [H2] of >10 ppm above the baseline value, within the 3 hours 
(12).  
 LHBT results were interpreted by an experienced gastroenterologist who was blinded to the 
results of the MRI. Data were analyzed in order to detect the presence of an asymptomatic SIBO, 
using both traditional double peak criteria (i.e., abnormal test was defined by a 12 ppm [H2] 
increase in breath over baseline with ≥5 ppm decrease at two or more points before the second 
peak) (11) and Pimentel criteria (i.e. an abnormal test was defined by a [H2] rise within 90 minutes 
or an absolute change >20 ppm within 180 min) (20).  
 
MRI Analysis 
Using T2-weighed sequences, the lactulose fluid bolus appears hyperintense within an empty GI 
tract and the passage of the bolus can be tracked easily by visual inspection on sequential axial 
images during MRI examination (Figure 1). Coronal images were used to confirm bolus 
progression only when axial images analysis was uncertain. Bolus detection was performed by two 
radiologists with more than eight and three years’ experience in abdominal MRI who were blinded 
to LHBT results. OCTT obtained using MRI (MR-OCTT) was defined as the time elapsed between 
lactulose ingestion and its detection in the caecum. 
Gas appears as signal void within the bowel. To calculate SBGV, we analysed each single 
MR image separately using a freeware software (OsiriX, v. 3.6.1, Pixmeo SARL, Bern, 
Switzerland) that allows for drawing grow segmentation regions with a semi-automatic method. 
The cursor was placed in the middle of the signal void area and the software automatically creates a 
region of interest that includes all pixels with grey levels similar to those selected. The threshold 
interval of grey levels to be included could be modified by the operator to make the analysis taking 
into account the highest area of signal void pixels (Figure 2). The area obtained with this 
segmentation were multiplied by the thickness of each slice (7 mm) to obtain the SBGV. Image 
processing was performed by the same radiologist with more than eight years’ experience in 
abdominal MR and image elaboration who were blinded to LHBT results. 
 
Statistical Analysis 
Age and body mass index were reported as mean±standard deviation. Other continuous variables 
with non-parametric distribution were reported as median and interquartile range. These included, 
[H2], [CH4], and SBGV. BT-OCTT and MR-OCTT were considered as a discrete variables, being 
measured in steps of 15 minutes. 
The primary analysis compared BT-OCTT to the MR-OCTT using the Wilcoxon signed 
rank test, while agreement between these variables was estimated using the Cohen kappa statistics. 
A preliminary inspection of the data revealed that the relationship between breath [H2] above 
baseline levels (i.e. <5ppm) and the SBGV above baseline levels (i.e. <5ml, see results) was linear. 
The data at each time point was fitted using a linear regression. Correlation between [CH4] and 
SBGV was estimated using the Pearson correlation coefficient. Interobserver variability in 
MR-OCTT detection at MR was assessed by Cohen kappa statistics with a value of >0.8 
representing near perfect agreement. 
Calculations were performed using SPSS Statistics v. 17 (SPSS, Chicago, IL) and Excel 
(Microsoft 2007, Redmond, WA). A P-value less than 0.05 was considered as significant. 
Results 
Study Population 
It comprised 28 healthy volunteers (30±8 years; 17 males [30±7 years]; 11 females [30±9 years]). 
Mean body mass index was 22±3 kg/m
2
, 4/28 (14%) were alcohol consumers, 3/28 (11%) were 
coffee consumers, and 15/28 (54%) were smokers. All subjects were asymptomatic (GSS score=0).  
No adverse reactions were reported. In two cases, the test was postponed due to the presence 
of abnormal quantity of fluids in the stomach and was performed by prolonging the fasting period. 
No subject complained of any symptoms during the testing period.  
 
LHBT Data 
Among 28 subjects, 26 were H2 producers and 8 CH4 producers. The median baseline H2 
concentration was 2 ppm (1-4 ppm) and increases of [H2] above 5 ppm were considered significant 
(8). The baseline CH4 concentration was 0 ppm (0-8 ppm).  
Median BT-OCTT was 127.5 minutes (105-150 min). The two non-H2 producers were 
excluded from this analysis. Median excretion values of H2 and CH4 over time are shown in Figure 
3. 
Based on traditional double peak criteria, SIBO was present in 3/28 (11%) subjects, while 
based on Pimentel criteria, SIBO was present in 5/28 (18%) individuals.  
 
MRI Data 
Interobserver agreement for MR-OCTT detection was excellent (Cohen k=0.92) between the two 
observers. Median MR-OCTT was 135 minutes (120-150 minutes). In the two patients that were 
non-H2 producers, MR-OCTT was 105 and 180 minutes, while LHBT was blinded for this 
assessment.  
At baseline, MRI detected a median SBGV of 49.0 mL (interquartile interval 44.1-51.6 mL). 
Oral administration of lactulose solution was followed by a progressive increase of SBGV (Figure 
4).  
 
Correlation Analysis 
In 2/28 (8%) cases, MR-OCTT and BT-OCTT could not be compared because patients were H2 
non-producers. In the remaining 26 subjects, median MR-OCTT (135 minutes) was significantly 
longer (P=0.008) than the median BT-OCTT (127.5 minutes) (Figure 5). However, the difference 
(7.5 minutes) was lower than the interval between two measurement time points. Agreement 
between BT-OCTT and MR-OCTT was almost perfect (k=0.924). Lactulose bolus reaching the 
caecum was detected at the same time by MRI and LHBT in 18/26 (69%) subjects. In the remaining 
8/26 (31%) individuals with discordant results, MR-OCTT was longer than BT-OCTT. In each of 
these 8 cases, MRI showed that the lactulose bolus was in the terminal ileum and not yet in the 
caecum and MR-OCTT was longer than BT-OCTT by one (n=6) or two (n=2) time points.  
Considering SIBO individuals diagnosed by LHBT in detail: in 3/26 (12%) subjects, SIBO 
was identified using the traditional double peak criteria and MRI confirmed the diagnosis in 2 cases, 
since the initial H2E peak during the LHBT appeared before the lactulose bolus entered the cecum 
on MRI. Regarding the third subject, the initial H2E peak was associated to the lactulose bolus 
detection into the caecum in the presence of accelerated MR-OCCT (i.e., false positive). In 5/26 
(19%) individuals, SIBO was identified by Pimentel criteria and MRI confirmed the diagnosis in 
three, while two cases were false positive due to an accelerated OCCT. Thus, the LHBT diagnosis 
of SIBO was confirmed by the combined test in 5 cases, whereas 3/8 (38%) subjects had 
false-positive LHBT due to rapid transit. 
The significant correlation between [H2] and SBGV is shown in Figure 6, where each dot 
represents medians at a given timepoint starting from 105 minutes after lactulose ingestion 
(r=0.964, P<0.001). No correlation between [CH4] and SBGV was found (r=0.168, P=0.573) in 
CH4 producers patients.
Discussion 
This study demonstrates high agreement for measurements of MR-OCTT and BT-OCTT with 69% 
of cases showing the same value and 92% of patients showing a difference between the two 
observed values of only one time point (i.e., <15 minutes). Additionally, correlation between the 
increase in H2E in the breath during LHBT and SBGV measured by MRI was significant. This 
implies that MRI is both a valid method for measurement of OCTT and also provides direct 
evidence of bacterial fermentation in the small bowel and a novel diagnostic test for SIBO. 
Currently, evaluation of OCTT is challenging because of the important drawbacks of the 
available techniques (9-17). LHBT is a simple, non-invasive and widely-used test that provides 
indirect measurement of OCTT based on the time from lactulose ingestion to metabolism by colonic 
microbiota and an increase in breath H2E; however, it can be confounded by the presence of SIBO 
and H2 non-producers (i.e., colonic microbiota that does not produce H2) (10,11,22,23,27). 
Scintigraphy requires ingestion of a radioactive meal, evaluated with sequential scans over several 
hours. Scintigraphy has good sensitivity and specificity providing similar measurements of OCTT 
by using both solid and liquid meal (28), but is time consuming, relatively costly, sometimes 
difficult to interpret due to overlapping loops of small intestine and the caecum, and utilizes 
ionizing radiations (8,28). MRI was recently applied to evaluate GI structure and function (29-31) 
and to detect the presence of gas or liquids and the movement of fluid through the GI tract (32-34). 
In particular, Chaddock et al. measured OCTT using MRI and lactose-ureide breath test, showing 
poor correlation between these methods when analyzed after administration of a meal (15).  
In our series, OCTT measurements varied widely between 90 and 180 minutes; however, 
agreement between the two techniques was maintained across the observed range. Overall, there 
was a small but significant difference between BT-OCTT and MR-OCTT. This difference was 
within the temporal resolution of measurement acquisition (15 minutes) and would normally be 
considered clinically irrelevant; however, it is of interest because it reflects a systematic difference 
between the two investigations. The >10ppm increase in breath hydrogen that occurred in 31% of 
subjects before MRI documented the arrival of the lactulose fluid bolus in the cecum indicates that 
bacterial colonization was present in the small bowel in a proportion of subjects as previously 
suggested (35,36). Detailed examination of the LHBT and MRI results revealed that in all cases the 
“early” increase in breath hydrogen occurred during 15 to maximum 30 minutes stasis of the 
lactulose fluid bolus in the terminal ileum. This finding confirms that SIBO limited to the terminal 
ileum should be considered normal. However, more extensive SIBO that causes a rise in breath 
hydrogen >30 minutes before arrival of contrast in the cecum may indicate clinically relevant SIBO 
in patients with enteric dysmotility (e.g. systemic sclerosis) or functional gastrointestinal disease 
(26). This issue may be clinically relevant, as this may also identify patients with IBS with diarrhea 
that respond to antibiotic therapy (8). 
The presence of H2 non-producers in 8% of the population (2% - 43% reported in the 
literature) (11,22,37,38), the high degree of variability in OCTT and the discrepancy between 
OCTT measurements documented by LHBT and MRI in some individuals, all indicate that LHBT 
alone does not provide an accurate measurement of gastrointestinal function. Moreover, addition of 
CH4 measurements were “positive” in only a small number of individuals and a distinct increase of 
CH4 on entry into the caecum was not present. The combined LHBT-MRI test is not affected by 
these limitations and may potentially represent a good alternative approach. Indeed, MRI 
observations revealed that in about half of the healthy volunteers in whom SIBO was “diagnosed” 
on the basis of LHBT results were confounded by variation in OCTT and were not due abnormal 
distribution of bacteria in the small bowel. These data are in agreement with those reported by Yu et 
al. (2) and Zhao et al. (8) in IBS patients using combined 99mTc scintigraphy and LHBT , showing 
that an “abnormal LHBT” using any of the published criteria cannot distinguish rapid OCTT from 
SIBO (39).  
Our observations suggest that MRI can provide also a direct assessment of gas production in 
the small bowel. Our data allowed us to evaluate the relationship between the H2E and the SBGV 
over time. After 90 minutes, the rapid rise in H2 excretion and SBGV was likely related to 
fermentation in the large bowel (± distal small bowel) with subsequent, retrograde passage of gas 
into the small bowel. A similar relationship was not observed between CH4 measurements and 
SBGV in those patients that produced methane. Clinically, these data suggest the potential to use 
MRI to estimate the amount of gas in the gut, that represents a crucial issue in patients with IBS and 
other GI disorders with abnormal gas dynamics. Additionally, MRI may facilitate assessment of the 
effect of drugs on gas production and transit within the gut.  
Two advantages of MRI over LHBT for assessment of OCTT should be emphasized. First, 
previous studies documented that lactulose may influence small bowel secretion that significantly 
accelerate OCTT (40). As MRI can detect most aqueous material within the gut, other material may 
be used to assess MR-OCTT; however these substrates should either retain sufficient intra-luminal 
fluid or be otherwise visualized moving through the bowel by MRI. Then, it is known that LHBT 
evaluation can be impaired by large residual stomach content (14); however, to date, no tools are 
available to evaluate whether stomach is empty or not prior to the test. As demonstrated in two 
participants, MRI is able to overcome this limitation by detecting excess gastric content at baseline. 
On the other hand, using MRI to measure OCTT has disadvantages. The long time needed to detect 
lactulose bolus in the caecum during MR make this method fairly expensive. Moreover, 
claustrophobia and contraindications to MRI may somewhat limit the applicability in clinical 
practice. 
This study has limitations. First, the sample size is relatively low; however, this represents 
the first report of combined MRI and LHBT to investigate gastrointestinal function. Also, the use of 
LHBT as reference standard can be questioned, but since there is no consensus on which is the best 
technique for measuring OCTT we opted to use it because it is safe, cheap and easy-to-perform in 
combination with MRI compared to other methods (e.g., scintigraphy) and because the lactulose 
fluid bolus represents a good substrate to follow using MRI. It may be relevant that the MR 
examination is performed in supine position. In this series, the median BT-OCTT was longer than 
101 min obtained in a previous study in a large number of healthy volunteers in the seated position 
(26). An upright position may promote gastric emptying and bolus transit through the small 
intestine as documented by previous MRI studies (30,31); however any effect is likely to be small 
and unlikely to confound diagnosis of SIBO using the combined technique. Finally, inter observer 
agreement of MR-OCTT measurements was near perfect, but we did not test reproducibility of 
combined MRI-LHBT examination. 
In conclusion, our study demonstrates that MRI represents a valid, non-invasive, 
radiation-free modality that provides a direct measurement of OCTT; its combination with LHBT 
may also allow non-invasive detection of patients with SIBO. Moreover, measurement of gas 
production in the small bowel by MRI after ingestion of lactulose may provide direct evidence of 
bacterial fermentation. Ongoing studies will examine whether the combined LHBT-MRI technique 
detects clinically relevant abnormalities of small bowel function and transit in patients with 
functional GI diseases that may be amenable to specific treatments. 
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Figure Legends 
 
Figure 1. Magnetic resonance evaluation of the upper and lower abdomen, axial T2-weighted 
steady-state fast spin-echo sequences, performed in a 32 year-old asymptomatic subject. (a) 
baseline, pelvic scan. Some small bowel loops are distended by gas (red line) while others have 
virtual lumen (asterisks); caecum is distended by stool (green dotted line). (b) upper abdomen scan 
performed immediately after oral administration of lactulose. The stomach is distended (blue 
dashed line) and a gas-fluid level can be seen (A=air; F=fluid). (c) pelvic scan performed 75 
minutes after oral administration of lactulose. Some small bowel loops are distended by fluid (red 
dashed line), while others have virtual lumen (asterisks); caecum (green dashed line) and the 
colon-sigma junction (yellow dashed line) are distended by stool. (d) pelvic scan performed 135 
minutes after oral administration of lactulose. Some small bowel loops are distended by fluid (red 
dashed line), while others have virtual lumen; air can be seen in other loops (asterisks). Compared 
to (c), high signal can be appreciated inside the caecum (green line), indicating that the fluid bolus 
has entered the caecum. The colon-sigma junction is distended by stool (yellow dashed line). 
 
Figure 2. Semi-automatic segmentation of gas within small bowel lumen. The green line represents 
the area selected for volume calculation. 
 
Figure 3. Median H2 (a) and CH4 (b) excretion over time in asymptomatic subjects after oral 
administration of a bolus of diluted lactulose. Bars refer to interquartile ranges. 
 
Figure 4. Median small bowel gas volume (SBGV) over time measured using MRI in 
asymptomatic subjects after oral administration of a bolus of diluted lactulose. 
 
Figure 5. Comparison between oro-caecal transit time (OCTT) measured in min using LHBT and 
MRI in asymptomatic subjects after oral administration of a bolus of diluted lactulose. Bars refer to 
standard deviations. Data are expressed in minutes. 
 
Figure 6. Graph showing the relationship between H2 excretion and the small-bowel gas volume 
(SBGV). Each dot represents the medians at a given timepoint, starting from 105 minutes. 
